Literature DB >> 1399145

Cytotoxicity of a transferrin-adriamycin conjugate to anthracycline-resistant cells.

M Fritzer1, K Barabas, V Szüts, A Berczi, T Szekeres, W P Faulk, H Goldenberg.   

Abstract

Conjugates of adriamycin coupled to transferrin by glutaraldehyde are cytotoxic to human promyelocytic (HL-60) and erythroleukemic (K562) cells. Growth inhibition of adriamycin-sensitive cells, as evaluated by thymidine incorporation and the MTT-assay, was higher for conjugates than for free adriamycin. The cytotoxicity toward adriamycin-resistant K562 and HL-60 cells was 3-fold and more than 10-fold higher, respectively, for the transferrin-adriamycin conjugate than for the free drug. The effect of the conjugate was dependent on its adriamycin content, i.e., on its conjugation number.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1399145     DOI: 10.1002/ijc.2910520421

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer?

Authors:  Yulu Zhou; Yong Shen; Cong Chen; Xinbing Sui; Jingjing Yang; Linbo Wang; Jichun Zhou
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

2.  Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.

Authors:  Ping Ma; Russell J Mumper
Journal:  Nano Today       Date:  2013-06-01       Impact factor: 20.722

Review 3.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

Authors:  Tracy R Daniels; Ezequiel Bernabeu; José A Rodríguez; Shabnum Patel; Maggie Kozman; Diego A Chiappetta; Eggehard Holler; Julia Y Ljubimova; Gustavo Helguera; Manuel L Penichet
Journal:  Biochim Biophys Acta       Date:  2011-08-05

4.  Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase.

Authors:  T Szekeres; K Gharehbaghi; M Fritzer; M Woody; A Srivastava; B van't Riet; H N Jayaram; H L Elford
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Direct evaluation of intracellular accumulation of free and polymer-bound anthracyclines.

Authors:  T Bogush; G Smirnova; I Shubina; A Syrkin; J Robert
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 6.  Biomechanics and biophysics of cancer cells.

Authors:  Subra Suresh
Journal:  Acta Biomater       Date:  2007-05-30       Impact factor: 8.947

Review 7.  Cancer Targeting and Drug Delivery Using Carbon-Based Quantum Dots and Nanotubes.

Authors:  Joel Pardo; Zhili Peng; Roger M Leblanc
Journal:  Molecules       Date:  2018-02-10       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.